• 25 October, 2026

Graviti Pharma accelerates India expansion with launch of Karnataka operations

Graviti Pharmaceuticals, a Hyderabad-based pharmaceutical company with...

April 23, 2026 | Thursday | News
Amneal Pharma to acquire Kashiv BioSciences to create fully integrated global biosimilar leader

Kashiv BioSciences has entered into a definitive agreement to be acqui...

April 23, 2026 | Thursday | News
Raay Neo Pharma launches to transform India's healthcare landscape

Raay Neo Pharma, a next-generation pharmaceutical company, has officia...

April 21, 2026 | Tuesday | News
Zyax Chem secures 26% stake in Gaymed Labs to focus on eye care

Varun Mukhi is leading Mumbai-based Zyax Chem’s next phase of gr...

April 21, 2026 | Tuesday | News
Rubicon Research enters CNS formulations market with acquisition of Arinna Lifesciences

Rubicon Research has announced the acquisition of an 85% equity owners...

April 15, 2026 | Wednesday | News
MSN Laboratories launches SEMABEST, the first integrated Made-in-India Semaglutide

MSN Laboratories has announced the launch of SEMABEST, its s...

April 15, 2026 | Wednesday | News
‘India Pharma 2026’ concludes with strong call for enhanced funding, infrastructure and speed to drive pharma innovation

The 9th edition of ‘India Pharma 2026’, the flagship event...

April 14, 2026 | Tuesday | News
Pharma Sector should intensify focus on innovation-driven segments: Anupriya Patel

The 9th edition of India Pharma 2026, the flagship even...

April 13, 2026 | Monday | News
Cadila Pharma unveils new therapy for BP control

Ahmedabad-based Cadila Pharmaceuticals has announced the launch of Cil...

April 12, 2026 | Sunday | News
Semaglutide Volumes Surge 2X+, but Value Growth Lags Amid Aggressive Generic Pricing in April 2026: Sheetal Sapale

April 2026 is expected to highlight a clear divergence between volume ...

April 10, 2026 | Friday | News
Semaglutide Generics Disrupt GLP-1 Market, Erode Tirzepatide Dominance: Sheetal Sapale

The GLP-1 agonist segment witnessed a significant transformation in Ma...

April 10, 2026 | Friday | News
Semaglutide Generics to Reshape Rs 1,579 Cr GLP-1 Market: Sheetal Sapale

India’s GLP-1 agonist market has undergone a dramatic transforma...

April 10, 2026 | Friday | News
Novo Nordisk Loses Grip as Indian Pharma Disrupts Semaglutide Market: PHARMATRAC

The Indian semaglutide market is witnessing a rapid and meaningful shi...

April 10, 2026 | Friday | News
Novo Nordisk Holds Ground as Eli Lilly’s Share Falls by 13% Amid Rs 59 Cr Semaglutide Market Surge: PHARMATRAC

The Indian GLP-1 therapy market is undergoing a sharp competitive shif...

April 10, 2026 | Friday | News
Leeford builds science-led skincare presence with Alite

Punjab-based Leeford Healthcare is targeting the fast-growing health a...

April 8, 2026 | Wednesday | News
Emcure reduces price of weight management drug Poviztra by 55%

Emcure Pharmaceuticals has announced the price revision of its weight ...

April 2, 2026 | Thursday | News
Bayer simplifies access to innovative eye care in India with Eylea 2mg

Bayer has reaffirmed its commitment to simplifying access to innovatio...

April 2, 2026 | Thursday | News
Novo Nordisk India sets patient-centred price of Rs 202/day for starting dose of Ozempic® and Wegovy®

Novo Nordisk India has announced price reductions for its original and...

March 31, 2026 | Tuesday | News

Trending Topics

Most Read

Survey Box

Are Biosuppliers embedding themselves in India’s innovation ecosystem?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Login with Google
OR

Forgot your password?

Login with Google
OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy